Cationic Amphiphiles with Specificity against Gram-Positive and Gram-Negative Bacteria: Chemical Composition and Architecture Combat Bacterial Membranes
- PMID: 30888181
- PMCID: PMC6832706
- DOI: 10.1021/acs.langmuir.9b00110
Cationic Amphiphiles with Specificity against Gram-Positive and Gram-Negative Bacteria: Chemical Composition and Architecture Combat Bacterial Membranes
Abstract
Small-molecule cationic amphiphiles (CAms) were designed to combat the rapid rise in drug-resistant bacteria. CAms were designed to target and compromise the structural integrity of bacteria membranes, leading to cell rupture and death. Discrete structural features of CAms were varied, and structure-activity relationship studies were performed to guide the rational design of potent antimicrobials with desirable selectivity and cytocompatibility profiles. In particular, the effects of cationic conformational flexibility, hydrophobic domain flexibility, and hydrophobic domain architecture were evaluated. Their influence on antimicrobial efficacy in Gram-positive and Gram-negative bacteria was determined, and their safety profiles were established by assessing their impact on mammalian cells. All CAms have a potent activity against bacteria, and hydrophobic domain rigidity and branched architecture contribute to specificity. The insights gained from this project will aid in the optimization of CAm structures.
Conflict of interest statement
The authors declare no competing financial interest.
Figures









Similar articles
-
Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.Eur J Med Chem. 2018 Jul 15;155:925-945. doi: 10.1016/j.ejmech.2018.06.054. Epub 2018 Jun 23. Eur J Med Chem. 2018. PMID: 29966917
-
Recent development of membrane-active molecules as antibacterial agents.Eur J Med Chem. 2019 Dec 15;184:111743. doi: 10.1016/j.ejmech.2019.111743. Epub 2019 Sep 27. Eur J Med Chem. 2019. PMID: 31586478 Review.
-
Amphiphilic cationic β(3R3)-peptides: membrane active peptidomimetics and their potential as antimicrobial agents.Biomacromolecules. 2014 May 12;15(5):1687-95. doi: 10.1021/bm500101w. Epub 2014 Apr 15. Biomacromolecules. 2014. PMID: 24694059
-
Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agents.Org Biomol Chem. 2015 Jun 14;13(22):6225-41. doi: 10.1039/c5ob00621j. Org Biomol Chem. 2015. PMID: 25958967
-
Molecular mechanisms of membrane targeting antibiotics.Biochim Biophys Acta. 2016 May;1858(5):980-7. doi: 10.1016/j.bbamem.2015.10.018. Epub 2015 Oct 26. Biochim Biophys Acta. 2016. PMID: 26514603 Review.
Cited by
-
Harnessing the Role of Bacterial Plasma Membrane Modifications for the Development of Sustainable Membranotropic Phytotherapeutics.Membranes (Basel). 2022 Sep 22;12(10):914. doi: 10.3390/membranes12100914. Membranes (Basel). 2022. PMID: 36295673 Free PMC article. Review.
-
Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.Pathog Dis. 2019 Nov 1;77(8):ftz059. doi: 10.1093/femspd/ftz059. Pathog Dis. 2019. PMID: 31603505 Free PMC article.
-
Bactericidal Effect and Mechanism of Polyhexamethylene Biguanide (PHMB) on Pathogenic Bacteria in Marine Aquaculture.Biology (Basel). 2025 Apr 25;14(5):470. doi: 10.3390/biology14050470. Biology (Basel). 2025. PMID: 40427659 Free PMC article.
-
Combinatorial Screening of Cationic Lipidoids Reveals How Molecular Conformation Affects Membrane-Targeting Antimicrobial Activity.ACS Appl Mater Interfaces. 2023 Aug 30;15(34):40178-40190. doi: 10.1021/acsami.3c05481. Epub 2023 Aug 21. ACS Appl Mater Interfaces. 2023. PMID: 37602460 Free PMC article.
-
Machine Learning Algorithm Identifies an Antibiotic Vocabulary for Permeating Gram-Negative Bacteria.J Chem Inf Model. 2020 Jun 22;60(6):2838-2847. doi: 10.1021/acs.jcim.0c00352. Epub 2020 Jun 9. J Chem Inf Model. 2020. PMID: 32453589 Free PMC article.
References
-
- Dellit TH; Owens RC; McGowan JE; Gerding DN; Weinstein RA; Burke JP; Huskins WC; Paterson DL; Fishman NO; Carpenter CF; Brennan M; Hooton TM Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis 2007, 44, 159–177. - PubMed
-
- Boucher HW; Talbot GH; Bradley JS; Edwards JE; Gilbert D; Rice LB; Scheld M; Spellberg B; Bartlett J Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis 2009, 48, 1–12. - PubMed
-
- Zasloff M Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389–395. - PubMed
-
- Brogden KA Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol 2005, 3, 238. - PubMed